Key facts
- EndoStart’s last known valuation is $2.4M (Dec 2018).
- It has raised $23.0M; the latest was Later Stage VC ($1.1M) in May 2025.
- Notable investors include LIFTT, Panakes Partners, Carlo Marcoaldi, EUREKA! Venture SGR, Estor — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for EndoStart
- ·The full record, as it builds
Funding rounds
No funding rounds for EndoStart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EndoStart
Developer of colonoscopy technology and devices designed to guide and navigate colonoscopy procedures. The company's technologies consist of a magnetic balloon guide, a ferrofluid syringe, and a multi-use magnetic handpiece and offer advanced, precision-engineered devices to perform procedures with improved efficiency and accuracy, enhancing patient care in the medical field, enabling doctors to reduce the wall stress and the need for general anesthesia.
- Sector
- Healthcare
- HQ
- Certaldo, Italy
- Founded
- 2018
- Employees
- 17
- Website
- endostart.com/
- Ownership
- Privately Held (backing)
EndoStart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EndoStart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EndoStart in its N-PORT filings yet. We sweep new filings monthly.